Q4 2024 Ngl Fine Chem Ltd Earnings Call Transcript
Key Points
- Revenue from operations grew by 21.8% year on year to INR338.69 crores, driven by strong volume growth across the product portfolio.
- EBITDA increased by 55.22% to INR53.27 crores, with EBITDA margins expanding by 339 basis points to 15.7%.
- Profit after tax nearly doubled to INR41.32 crores from INR20.50 crores in the previous year.
- Significant reduction in raw material costs contributed to normalized margin levels and overall financial improvement.
- Strategic focus on maintaining a diversified product portfolio and not relying excessively on any single product, customer, or geography has been effective.
- Subdued demand, higher customer inventory levels, and currency volatility in key markets like Egypt, Pakistan, and Turkey initially constrained performance.
- Intense pricing pressures created a highly competitive landscape, impacting margins.
- Other expenses saw a sharp increase, particularly in the last two quarters, driven by higher power and fuel costs.
- Employee costs increased significantly, partly due to salary hikes and additional hiring to meet production requirements.
- The company faces delays in European product registrations, with approvals taking longer than initially expected.
Ladies and gentlemen, good day, and welcome to the Q4 and FY24 earnings conference call of NGL Fine-Chem Limited.(Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Abhishek Mehra from TIL Advisors. Thank you, and over to you, sir.
Good afternoon, everyone, and thank you for joining this Q4 and FY24 earnings conference call of NGL Fine-Chem Limited. The results and investor update have been uploaded on the stock exchange.
To take us through the results of this quarter and answer your questions, we have with today, Mr. Rahul Nachane, Managing Director; and Mr. Rajesh Lawande, Whole-Time Director and Chief Financial Officer. We'll be starting the call with a brief overview of the financial performance, which will then be followed by the Q&A session.
I want to remind you all that everything said on this call, reflecting any outlook for the future, which can be construed as a forward-looking statement must be viewed in conjunction with
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
